- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Volume 2012 (2012), Article ID 215810, 17 pages
Imaging Features of Superficial and Deep Fibromatoses in the Adult Population
1Department of Radiology, Penn State Milton S. Hershey Medical Center, Penn State College of Medicine, 500 University Drive, Hershey, PA 17033, USA
2Department of Radiology and Nuclear Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA
3American Institute for Radiologic Pathology, 1010 Wayne Avenue, Suite 320, Silver Spring, MD 20910, USA
4Department of Radiology, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, USA
Received 1 January 2012; Accepted 30 March 2012
Academic Editor: Leslie G. Dodd
Copyright © 2012 Eric A. Walker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The fibromatoses are a group of benign fibroblastic proliferations that vary from benign to intermediate in biological behavior. This article will discuss imaging characteristics and patient demographics of the adult type superficial (fascial) and deep (musculoaponeurotic) fibromatoses. The imaging appearance of these lesions can be characteristic (particularly when using magnetic resonance imaging). Palmar fibromatosis demonstrates multiple nodular or band-like soft tissue masses arising from the proximal palmar aponeurosis and extending along the subcutaneous tissues of the finger in parallel to the flexor tendons. T1 and T2-weighted signal intensity can vary from low (higher collagen) to intermediate (higher cellularity), similar to the other fibromatoses. Plantar fibromatosis manifests as superficial lesions along the deep plantar aponeurosis, which typically blend with the adjacent plantar musculature. Linear tails of extension (“fascial tail sign”) along the aponeurosis are frequent. Extraabdominal and abdominal wall fibromatosis often appear as a heterogeneous lesion with low signal intensity bands on all pulse sequences and linear fascial extensions (“fascial tail” sign) with MR imaging. Mesenteric fibromatosis usually demonstrates a soft tissue density on CT with radiating strands projecting into the adjacent mesenteric fat. When imaging is combined with patient demographics, a diagnosis can frequently be obtained.
The fibromatoses are a broad group of fibroblastic proliferations with a similar histologic appearance containing spindle-shaped myofibroblastic cells, dense deposits of intercellular collagen fibers, variable amounts of extracellular myxoid matrix, and compressed and elongated vessels . They vary from benign to intermediate in biological behavior. Intermediately aggressive lesions (locally aggressive) are characterized by infiltrative growth and local recurrence but an inability to metastasize  (Table 1). This paper will discuss imaging characteristics and patient demographics of the adult type superficial (fascial) and deep (musculoaponeurotic) fibromatoses. The imaging appearance of these lesions can be characteristic (particularly when using magnetic resonance imaging). When imaging is combined with patient demographics, a diagnosis can frequently be obtained. Primarily pediatric fibrous lesions such as juvenile aponeurotic fibroma, infantile digital fibromatosis, infantile myofibromatosis, fibromatosis colli, and aggressive infantile fibromatosis are not included in this paper.
2. Superficial Fibromatoses
The superficial (fascial) fibromatoses arise from fascia or aponeuroses at palmar, plantar, penile (Peyronie disease), and knuckle pad locations. Of the superficial fibromatoses, palmar fibromatosis is the most common followed by plantar fibromatosis [3, 4].
3. Palmar Fibromatosis
Palmar fibromatosis (Dupuytren disease) is the most common of the superficial fibromatosis, affecting 1%-2% of the general population and approximately 4% of the United States population [5–7]. It was first described by Dupuytren at the Hôtel-Dieu in 1831 and thus is also referred to as Dupuytren disease or contracture . Palmar fibromatosis is rare in Asian and African populations but frequent in the Northern European countries of Norway, Iceland, and Scotland, with prevalence rates between 30% and 39% [7, 9].
The etiology of palmar fibromatosis is believed to be multifactorial, including components of trauma, microvascular injury, immunologic processes, and genetic factors.
Patients are typically over 65 years of age and the process is rarely seen in children. Males are affected 3-4 times more often than females and the disease is more severe in men .
Clinically, patients present with painless, subcutaneous nodules involving the palmar aspects of the fingers, usually the fourth and fifth digits [2, 11]. The nodules may progress over months or years to fibrous cords or bands which attach to and cause traction on the underlying flexor tendons of the fingers . This results in the flexion contractures known as Dupuytren contractures. The process is bilateral in 40–60% of patients . Coexisting conditions include plantar fibromatosis, Peyronie disease, knuckle pad fibromatosis, diabetes mellitus, epilepsy, alcoholism, manual labor with vibration exposure, smoking, hyperlipidemia, complex regional pain syndrome, and keloids [3, 6, 13].
Surgical intervention remains the treatment of choice, typically a selective fasciotomy. The decision to undergo surgical excision is determined by both patient symptoms and the presence of flexion contracture greater than 20 degrees at the metacarpophalangeal (MCP) joint or greater than 30 degrees at the proximal interphalangeal (PIP) joint . A simple surgical excision is associated with a high rate of local recurrence (30% to 40%), frequently within one year [4, 15].
Radiographs may be normal or demonstrate flexion (Dupuytren) contractures of the MCP and PIP joints (Figure 1(a)).
On ultrasonography, the subcutaneous nodules of palmar fibromatosis are generally hypoechoic, hypervascular, and superficial to the flexor tendons [16, 17]. The extent of flexor tendon contracture can be assessed with dynamic ultrasonography.
Computed Tomography (CT) demonstrates isoattenuated to slightly hyperattenuated nodular areas of subcutaneous thickening.
MR imaging (MR) demonstrates multiple nodular or band-like soft tissue masses arising from the proximal palmar aponeurosis to the flexor tendons . The nodules or bands of palmar fibromatosis usually measure between 2 and 10 mm in diameter. Signal characteristics have been shown to correlate with the cellularity of the lesions . Low T1- and T2-weighted signal intensity are seen in hypocellular lesions composed of abundant dense collagen (Figures 1(b) and 1(c)). Cellular lesions have intermediate T1- and T2-weighted signal intensity with diffuse enhancement after the administration of gadolinium contrast (Figure 1(d)) . This difference in MR signal intensity is important because the more cellular lesions have a higher local recurrence rate after excision . Thus, these lesions could be managed by follow-up MR imaging to assess for change to lower signal intensity as an indication of maturation and decreased cellularity and to direct the optimal time for surgical intervention.
4. Plantar Fibromatosis
Plantar fibromatosis (Ledderhose disease) (Morbus Ledderhose) occurs less frequently than the palmar lesion, with an incidence of 0.23% . In our institutions, Ledderhose disease is more frequently imaged than Dupuytren disease. The etiology of plantar fibromatosis remains controversial, with prior trauma considered likely. Chromosomal variations have been seen in some lesions .
Although the lesion can occur in children [21, 22], incidence increases with advancing age. In a large AFIP study (501 patients) 44% of patients were less than 30 years of age [1, 23]. Men are affected twice as often as females and lesions are bilateral in 20 to 50% of cases [22, 24].
Patients present with one or more subcutaneous nodules, which most frequently arise in the medial aspect of the plantar arch (78%) and can extend to the skin or deep structures of the foot. Nodules may be multiple in 33% of cases . Palmar fibromatosis is also present in 10% to 65% of patients with plantar fibromatosis. Other coexisting morbidities include diabetes mellitus, epilepsy, keloids, and alcoholism with liver disease [3, 21, 22, 26]. Most lesions are asymptomatic, only becoming symptomatic when the lesion invades adjacent structures such as neurovascular bundles, muscles, or tendons. Alternatively, some patients complain of aching pain after walking or standing for long periods of time. In contradistinction to palmar fibromatosis, plantar fibromatosis does not usually produce contraction deformities of the foot .
The treatment of plantar fibromatosis is often conservative and consists of footwear modifications aimed at relieving symptoms . Surgical resection is reserved for large lesions which cause significant disability and are refractory to nonoperative methods of management. Surgical treatment consisting of simple excision resulted in high rates of local recurrence (20%–40%), with the majority of lesions recurring within the first postoperative year .
Radiographs are frequently normal in patients with plantar fibromatosis.
Lesion evaluation is most commonly performed with ultrasound and MRI. Sonographic imaging demonstrates a well-defined (64%) or poorly defined (36%) fusiform mass in the soft tissues adjacent to the plantar aponeurosis (Figure 2(a)). Plantar fibroma may be heterogeneous and hypoechoic (76%) or isoechoic (24%) relative to the plantar fascia [3, 28]. Posterior acoustic enhancement (20%), cystic components, and intratumoral hypervascularity (8%) have also been described [28, 29].
CT images demonstrate a nonspecific soft tissue mass in the characteristic location with attenuation equal or higher than skeletal muscle .
MR imaging may demonstrate well-defined or ill-defined superficial lesions along the deep plantar aponeurosis, which typically blend with the adjacent plantar musculature. With its superior soft tissue contrast, MR is the best modality to determine infiltration of the lesion into the surrounding tissues and therefore it is most helpful for preoperative planning. Lesions typically show heterogeneous signal (92%), which is isointense to hypointense to skeletal muscle on T1W (100%) and T2W (78%) sequences. If the lesion has increased cellularity and less collagen, the T2 signal is increased (22%) . The degree of enhancement has been reported as marked in approximately 60% and mild in 33% of cases . Linear tails of extension (fascial tail sign) along the aponeurosis are frequent and best identified following intravenous contrast administration (Figure 2(b)) [3, 6].
5. Deep Fibromatoses
The deep fibromatoses are fibroblastic proliferations that arise within the deep soft tissues and are traditionally divided into extraabdominal, abdominal wall, and intraabdominal types. They demonstrate infiltrative growth and local recurrence but do not metastasize. Their biological behavior may be considered intermediate due to frequent local recurrence. Involvement of adjacent vital structures may lead to patient demise, particularly with neck and chest wall lesions. Recurrent extremity lesions may eventually require amputation for local control [3, 6]. The World Health Organization (WHO) now groups these lesions together under the term deep or desmoid-type fibromatoses . The term desmoid is derived from the Greek word desmos, meaning a band or tendon .
The overall incidence of desmoid type fibromatosis is two to four individuals per million each year [31, 32]. Relative frequency of the individual subtypes of deep fibromatosis has been reported as abdominal wall (49%), extraabdominal (43%), and mesenteric (8%) . Etiology is multifactorial with genetic, endocrine, and physical factors believed to play a role in pathogenesis. In the pediatric population there is an equal sex distribution and most lesions are extraabdominal. Patients from puberty to age 40 tend to be female and the abdominal wall is the most frequent site. After age 40, the sex distribution is again 1 : 1 with occurrence in abdominal wall and extraabdominal locations being approximately equal .
6. Extraabdominal Fibromatosis
Synonyms for extraabdominal fibromatosis include musculoaponeurotic fibromatosis, extraabdominal desmoid, desmoid tumor, well-differentiated nonmetastasizing fibrosarcoma, and aggressive fibromatosis [1, 6].
Extraabdominal fibromatosis is most common in patients between puberty and 40 years of age, with a peak incidence noted between the ages of 25 and 30 years. Less than 5% of patients are younger than 10 years of age . Women are more commonly affected than men [34, 35].
While these lesions can occur almost anywhere in the body, they have a predilection for the upper torso including the upper arm (28%), chest wall/paraspinal (17%), and head/neck (10% to 23%). Other less common locations include the thigh (12%), knee (7%), buttock/hip (6%), and forearms (4%). Lesions in the head and neck often behave more aggressively and may surround the axillary vessels, trachea, and brachial plexus, limiting the extent of surgical resection [3, 6]. Extraabdominal desmoids are usually centered in an intermuscular region, although invasion of muscle is frequent. Endocrine factors may play a role in the development and growth of extraabdominal fibromatosis (Figure 3) .
Although these tumors are usually solitary, synchronous multicentric lesions (Figure 4) are noted in 5% to 15% often in the same extremity (75% to 100%). Therefore a soft tissue mass in the extremity of a previously diagnosed desmoid tumor should be regarded as a second desmoid tumor until proven otherwise . Multicentric fibromatosis can be associated with a skeletal dysplasia [36, 37].
Extraabdominal fibromatoses typically present as a slow growing, painless mass which can limit range of motion of a nearby joint and invade adjacent neurovascular structures. Decreased range of motion, neurologic symptoms, and pain are reported but are unusual at presentation. Lesions are typically between 5 and 10 cm in size . Extraabdominal fibromatoses have a tendency to grow along fascial planes and can extend a great distance from the predominant mass.
The treatment of extraabdominal desmoid is usually a wide-local excision as it has a high tendency to locally recur. Traditionally, positive surgical tumor margins upon resection have been reported to be associated with a higher local recurrence rate. However, more recent studies have suggested that positive versus negative microscopic margins do not make a difference in the overall local recurrence rate [38, 39]. Adjuvant radiation therapy following surgery has been shown to decrease the local recurrence rate versus surgery alone. In fact various studies have suggested that radiation therapy alone (Figure 5) in inoperable cases achieves near equivalent local control compared to surgery . Additional therapies with reported positive results include radiofrequency ablation and chemotherapy agents such as Sorafenib (a multikinase inhibitor) and Imatinib (a protein-tyrosine kinase inhibitor) [39, 40]. Other modes of therapy include prostaglandin inhibitors and antiestrogen medications [41–43]. Although the lesion is not malignant, involvement of adjacent vital structures may lead to patient demise, particularly in lesions of the head/neck or chest wall .
Radiographs usually appear normal, although there may be signs of a soft tissue mass such as the failure to visualize the radiolucent cleavage plane between the soft tissue and bone, structural changes of the adjacent bone such as scalloping, or rarely soft tissue calcification or ossification may be seen . Bone involvement (Figure 6) is noted in 6% to 37% of cases [44, 45] and is more common after multiple recurrences .
Scintigraphy with Technetium-99m pertechnetate (Tc-99 m) has been used as a tumor scanning agent for follow-up of extraabdominal fibromatosis. Focal tracer accumulation is noted on blood pool and delayed static images .
Sonography of desmoid-type fibromatosis reveals a hypoechoic lesion [46–51]. The lesions are illdefined and welldefined in similar frequency . Color Doppler evaluation is useful in demonstrating vascularity of these lesions [6, 52]. Vascularity is absent in 66% of cases . Lesions may demonstrate prominent posterior acoustic shadowing [47, 48]. One author describes visualizing a “fascial tail” sign and staghorn pattern with the use of high frequency ultrasound probes . The “fascial tail” sign denotes linear tumor extension along the fascial planes and is described further in the section on MR imaging. The staghorn configuration corresponds to tumor extension of extraabdominal fibromatosis between subcutaneous fatty lobules. In our institutions, we use ultrasound primarily to guide needle biopsy of these lesions.
Computed Tomography (CT)
On CT, extraabdominal fibromatosis appears as a nonspecific soft tissue mass. Unless outlined by fat, the margins of the lesion are poorly defined. The attenuation of these tumors is variable, and has been described as lower than, similar to, or higher than skeletal muscle. Lesions with a higher attenuation are noted to have significant collagen components. One author suggests that a high attenuation lesion which is hypoechoic on ultrasound is suggestive of a fibrous lesion . The low attenuation lesion is the least common pattern and likely reflects a significant myxoid component . These lesions are well vascularized with numerous thick-walled capillaries resulting in enhancement on contrast enhanced CT and MR [54–56].
Magnetic Resonance Imaging (MR)
MR is frequently the modality of choice to evaluate and stage extraabdominal fibromatosis. Extraabdominal desmoid is usually centered in an intermuscular location, often along the deep fascia; therefore, a thin rim of surrounding fat may be noted (split-fat sign). Lesions may be well defined (49% to 54%) or have irregular infiltrative margins (46% to 51%) (Figure 8). T1-weighted sequences most often demonstrate lesions with intermediate signal intensity (isointense to muscle). The lesions are frequently heterogeneous, likely reflecting various proportions and distribution of collagen, spindle cells, and mucopolysaccharides within the lesion . Studies have shown that the signal intensity of desmoid tumors varies according to tumor cellularity, as lesions with high fibroblast content demonstrate higher T2 signal and less cellular lesions demonstrate a lower signal intensity .
Three histopathological stages of desmoid tumor have been described. In the first stage, lesions are more cellular (Figure 3(a)), with larger extracellular spaces and less areas of hyalinized collagen. In the second stage (Figures 3(b)–3(d)), lesions demonstrate increasing amounts of collagen in the central and peripheral regions of the tumor. In stage three, increased collagen content is appreciated, with decrease in lesion cellularity (Figure 12(c)) and water content [58, 59]. These changes are best appreciated using MR imaging. Each of the three stages demonstrates lower T1- and T2-weighted signal intensity than the previous stage with stage three lesions revealing signal characteristics approaching that of tendon.
The morphology of these low-signal areas as prominent band-like regions (Figures 5(a)–5(c)) is more important to suggest the diagnosis . These low-signal-intensity bands are common (62%–91% of cases) in desmoid type fibromatosis, compared with other neoplastic lesions, and are related to the collagenized, hypocellular bands seen at gross pathologic examination . Following gadolinium administration, these collagenized bands demonstrate lack of enhancement. The low-intensity bands correspond to the acellular collagen rich areas which are interspersed between the highly vascularized fascicles of spindle cells. The administration of gadolinium causes these collagen bands to stand out in relation to the enhancing cellular areas of the neoplasm. Specificity of this pattern of enhancement has been reported in as high as 91% of cases . Linear extension along fascial planes (fascial tail sign) (Figures 7(c) and 12(c)) is also a common manifestation of this lesion (83% of cases).
Signal intensity on long TR sequences may have an implication on tumor recurrence, with a higher recurrence rate in lesions with high T2 signal . Lesions that respond to radiation therapy demonstrate progressive collagenization and show low-signal intensity on low TR images, and decrease in lesion size . No significant enhancement is seen in approximately 10% of these lesions . Tumor margins vary significantly, although they are usually well defined at presentation [62, 63]. Extension of the tumor along the fascia is very suggestive of extraabdominal desmoid. The fascial tail sign may also be seen with nodular fasciitis, abdominal wall fibromatosis and plantar fibromatosis.
In lesions undergoing radiation or drug therapy, MR surveillance has been used to assess response to treatment (Figure 5) with a positive response demonstrating a decrease in T2 signal, lesion enhancement and lesion size [3, 33].
Although not routinely performed in most institutions, it has been reported that diffusion-weighted imaging may help differentiate desmoid tumors from malignant soft tissue tumors, with fibromatosis demonstrating a higher mean apparent diffusion coefficient (ADC) than malignant soft tissue tumors .
Areas of low T2-weighted signal are not specific to fibromatosis and may be seen with other lesions. A differential diagnosis for soft tissue lesions with prominent areas of low-signal intensity on T1- and T2-weighted sequences includes desmoid type fibromatosis, densely calcified mass, pigmented villonodular synovitis (PVNS)/giant cell tumor of tendon sheath (GCTTS), elastofibroma, granular cell tumor, desmoplastic fibroblastoma, and malignant fibrous histiocytoma (MFH)/fibrosarcoma .
Fluorodeoxyglucose Positron Emission Tomography (FDG PET)
FDG PET has been utilized to evaluated decreased metabolic activity of all types of deep fibromatosis during chemotherapy [65, 66]. Desmoid tumors demonstrate maximal standardized uptake values (SUVmax) ranging from 3.4 to 5.4 in the literature. Heterogeneous FDG uptake was the most common reported pattern (Figure 7(d)).
7. Abdominal Wall Fibromatosis
Abdominal wall fibromatosis is indistinguishable both grossly and histologically from extraabdominal fibromatosis and the relative frequency is similar. It is discussed separately because of its characteristic location and the tendency to occur in women of childbearing age (usually 20 to 30 years of age) during or more frequently within the first year following a pregnancy and in women who use oral contraceptives . It is the most common soft-tissue neoplasm of the abdominal wall. Abdominal wall desmoids are solitary slow growing neoplasms that are recognized for their progressive, locally infiltrative, and aggressive behavior. Desmoid tumors involving the abdominal wall affect women in approximately 87% of cases, with 95% of these patients having had at least one child [1, 67]. These lesions often arises from the rectus abdominis or internal oblique muscles and their fascial coverings . Abdominal wall desmoids tend to be smaller at detection than other types of deep fibromatosis (3 to 7 cm) likely because they become palpable at an earlier stage of lesion growth. A few cases have been reported in children of both genders. The majority of abdominal wall desmoids are solitary .
Clinical presentation is typically palpation of a firm, slowly growing painless soft tissue mass. Endocrine factors are most highly implicated in this form of deep fibromatosis by the frequent occurrence of these tumors during or in the year following pregnancy. Estrogen receptors have been reported in 79% of these lesions  and they have been reported to regress at menopause . Formation of these tumors in guinea pigs after prolonged estrogen exposure and prevention by administration of testosterone, progesterone, and desoxycorticosterone  as well as the estrogen inhibitors tamoxifen and raloxifen  has been reported. Similar to extraabdominal fibromatosis, abdominal wall fibromatosis may occur secondary to trauma. These lesions arise following a surgical procedure in 20% of cases, with 50% of these occurring within the first 4 postoperative years . Abdominal wall desmoids have been reported arising at radical nephrectomy sites  and at the site of peritoneal dialysis catheter insertion . Such lesions arising from scar tissue have been referred to as cicatricial fibromatosis. Abdominal wall fibromatoses may be associated with polyposis syndromes [74–76]. This is described in greater detail later in this paper.
These lesions frequently recur locally. The rate of local recurrence is reported to be 15% to 30%, less frequent than extraabdominal desmoid (35% to 65%) [49, 77]. Similar to extraabdominal fibromatosis, wide local excision is the treatment of choice, and adjuvant radiation therapy may be needed for inoperable or recurrent lesions [50, 78].
Imaging Features of Abdominal Desmoid
The radiologic features of abdominal wall desmoid, with all imaging modalities, are essentially identical to those of desmoid type fibromatosis in other locations. Involvement of the rectus abdominis muscle is most common (Figures 9 and 10). MR imaging is optimal for detecting the unusual manifestation of deep intraabdominal extension of tumor and guide resection. The fascial tail sign and low-signal-intensity bands (Figure 10(d)) also occur with abdominal wall desmoid and are valuable diagnostic clues .
8. Intraabdominal Fibromatosis
Intraabdominal fibromatosis (intraabdominal desmoid) is a rare group of closely related deep fibromatoses that occur in the pelvis, mesentery, and retroperitoneum (Figure 11). Despite their capacity to be locally aggressive, intraabdominal fibromatoses, like the other deep fibromatoses, do not metastasize . The etiology remains unknown.
Pelvic fibromatosis occurs in the iliac fossa and lower pelvis. It presents as a slowly growing palpable mass asymptomatic or causing slight pain. It is often mistaken for an ovarian neoplasm. The lesion occurs most frequently in women 20 to 35 years of age .
The small bowel mesentery (Figures 11(a) and 11(b)) is the most common location for intraabdominal fibromatosis  and mesenteric fibromatosis is the most common primary tumor of the mesentery. It accounts for 8% of deep fibromatosis .
Pelvic fibromatosis shows a female predilection, whereas mesenteric desmoids demonstrate a slight male predilection (55%) . The age range of occurrence of mesenteric fibromatosis is 14 to 75 years of age, with an average age of 41 years . They may become large before presentation, frequently 10 cm or more [1, 2].
Intraabdominal fibromatosis demonstrates sporadic occurrence, but the incidence is increased in patients with familial adenomatous polyposis (FAP), trauma or hyperestrogenic states [1, 52, 83]. Intraabdominal fibromatosis is the type most commonly associated with Gardner syndrome . Other hereditary disorders that are associated with mesenteric fibromatosis include familial infiltrative fibromatosis and hereditary desmoid disease .
The presenting clinical signs and symptoms of mesenteric fibromatosis are often related to the small bowel. Patients may complain of abdominal pain or a palpable abdominal mass or come to clinical attention because of complications such as gastrointestinal bleeding, small bowel obstruction, fistula formation, bowel perforation, or hydronephrosis [5, 85, 86]. A differential diagnosis for mesenteric desmoid tumor would include lymphoma, metastatic deposits, carcinoid, sclerosing mesenteritis, gastrointestinal stromal tumor (GIST) and mesenteric lipodystrophy.
Treatment options include surgical excision, hormone therapy, nonsteroidal anti-inflammatory drugs, and cytotoxic chemotherapy, although the optimal treatment regimen is controversial . While surgical resection may be curative in sporadic cases, local recurrence is frequently encountered in patients with FAP . There is a 23% overall recurrence rate (90% with Gardner syndrome and 12% without) .
Intraabdominal fibromatosis may result in local mass effect with displacement of adjacent bowel loops on radiographs (Figure 11(c)). Serosal changes can also be seen in the small bowel or colon mimicking mesenteric carcinoma or gastrointestinal stromal tumor (GIST) [79, 83].
Mesenteric masses may be discovered incidentally when patients are being evaluated for complaints of abdominal pain or discomfort. The sonographic appearance of mesenteric fibromatosis is a solid, well-circumscribed mass of variable echotexture and homogeneity [72, 80, 83].
Computed Tomography (CT)
Mesenteric fibromatosis usually demonstrates a soft tissue density with radiating strands projecting into the adjacent mesenteric fat (Figures 11(a) and 11(b)) and attenuation directly related to the underlying histology. They can be hypoattenuating hyperattenuating or appear whorled because of the alternating collagenous and myxoid areas. Contrast enhancement is variable [80, 88]. CT is frequently the modality of choice for detection and follow-up of intraabdominal fibromatosis. The intraabdominal fat makes the lesion more conspicuous and bowel motion causes less artifact than with MR imaging. A recent paper suggests that MRI is at least equivalent (and possibly superior) to CT for the detection of intraabdominal desmoid tumors in FAP with the advantage of avoiding radiation to the patient .
Most intraabdominal lesions are low or intermediate signal intensity on T1-weighted images and have heterogeneous low-, intermediate- or high-signal intensity on T2-weighted images. The relative amount of hyperintensity on T2-weighted images reflects the degree of high cellularity areas and myxoid stroma within the lesion. The intravenous contrast enhancement pattern of mesenteric fibromatosis with MR is variable. Lesions that do not significantly enhance with iodinated contrast material on CT scans have been shown to enhance with intravenous gadolinium on MR imaging [80, 86]. In a study of mesenteric desmoids in FAP, 32% of mesenteric lesions demonstrated a whorled appearance, the majority of which demonstrated low T1- and T2-weighted signal . Two papers concerning the MR characteristics of intraabdominal fibromatosis did not specifically mention a band-like pattern of low signal, but several of the figures appear to contain the characteristic band-like morphology [86, 90].
9. Deep Fibromatoses and Gardner Syndrome
Gardner syndrome is a variant of familial adenomatous polyposis (FAP) containing osteomas, thyroid cancer, epidermoid cysts, fibromas, sebaceous cysts, and desmoid tumors in addition to the colorectal adenomatous polyps (Figure 12).
Gardner syndrome is usually diagnosed in adults 25 to 30 years of age  and is more common in women. Approximately 2% of all desmoids are associated with FAP, and the incidence of desmoid tumors in FAP patients is approximately 850-fold greater than that of the general population . The desmoid tumors in Gardner syndrome are postulated to form as a result of a mutation which affects the beta-catenin signaling pathway, which is commonly associated with familial adenomatosis polyposis syndrome .
Patients with Gardner syndrome may demonstrate intraabdominal, abdominal wall, or musculoaponeurotic fibromatosis . Of the subtypes of intraabdominal desmoid tumor, the mesenteric desmoids are more likely to be associated with Gardner syndrome and the pelvic and retroperitoneal desmoids are usually of the isolated form [6, 95]. Prior abdominal surgery (colectomy) is a risk factor for the development of mesenteric fibromatosis in patients with FAP [80, 83]. Recent case studies have reported these tumors forming in response to surgical instrumentation [96–98].
Although similar in imaging characteristics to the isolated lesions, intraabdominal fibromatosis and other desmoid tumors associated with Gardner syndrome tend to be smaller and multiple and occur in a younger patient population. The smaller size and younger patient population may be secondary to more frequent imaging and follow-up examinations performed in patients with Gardner syndrome. Complications secondary to desmoid tumor are the most common cause of death in patients with FAP who have undergone prophylactic colectomy (30.6%) .
In summary, the deep and superficial fibromatoses vary from low- (higher collagen) to-intermediate (higher cellularity) T1 and T2-weighted signal intensity depending on lesion cellularity. Palmar fibromatosis may result in flexion (Dupuytren) contracture and plantar fibromatosis typically involves the medial cord of the plantar fascia and blends with the adjacent plantar musculature. A heterogeneous lesion (well-defined or ill-defined) with nonenhancing low-signal-intensity bands on all pulse sequences and linear fascial extensions (fascial tail sign) are highly suggestive of abdominal wall or extraabdominal desmoid . Mesenteric fibromatosis usually demonstrates a soft tissue density on CT with radiating strands projecting into the adjacent mesenteric fat. Patients with Gardner syndrome may demonstrate intraabdominal, abdominal wall or musculoaponeurotic fibromatosis. When imaging is combined with patient demographics, the diagnosis can frequently be suggested.
- S. W. Weiss, J. R. Goldblum, and F. M. Enzinger, “Fibromatoses,” in Enzinger and Weiss' Soft Tissue Tumors, S. W. Weiss and J. R. Goldblum, Eds., pp. 227–228, Mosby Elsevier, Philadelphia, Pa, USA, 2008.
- C. D. M. Fletcher, K. Krishnan Unni, and F. Mertens, Eds., Pathology and Genetics of Tumours of Soft Tissue and Bone (IARC WHO Classification of Tumours), 3rd edition, 2006.
- M. D. Murphey, C. M. Ruble, S. M. Tyszko, A. M. Zbojniewicz, B. K. Potter, and M. Miettinen, “From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation,” Radiographics, vol. 29, no. 7, pp. 2143–2176, 2009.
- J. Yost, T. Winters, and H. C. Fett, “Dupuytren's contracture: a statistical study,” The American Journal of Surgery, vol. 90, no. 4, pp. 568–571, 1955.
- R. L. Kempson, Armed Forces Institute of Pathology (U.S.), and Universities Associated for Research and Education in Pathology, Tumors of the Soft Tissues. Atlas of Tumor Pathology, Armed Forces Institute of Pathology, Washington, DC, USA, 3rd edition, 2001.
- M. J. Kransdorf and M. D. Murphey, Imaging of Soft Tissue Tumors, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 2006.
- S. Hindocha, D. A. McGrouther, and A. Bayat, “Epidemiological evaluation of dupuytren's disease incidence and prevalence rates in relation to etiology,” Hand, vol. 4, no. 3, pp. 256–269, 2009.
- R. B. Shaw Jr., A. K. Chong, A. Zhang, V. R. Hentz, and J. Chang, “Dupuytren's disease: history, diagnosis, and treatment,” Plastic and Reconstructive Surgery, vol. 120, no. 3, pp. 44e–54e, 2007.
- P. Burge, “Genetics of Dupuytren's disease,” Hand Clinics, vol. 15, no. 1, pp. 63–71, 1999.
- S. G. Anthony, S. A. Lozano-Calderon, B. P. Simmons, and J. B. Jupiter, “Gender ratio of dupuytren's disease in the modern U.S. population,” Hand, vol. 3, no. 2, pp. 87–90, 2008.
- S. Matthew, Dupuytren Contracture Clinical Presentation, Medscape, 2011.
- W. Laskin and S. Weiss, “Benign fibrous lesions,” in Tumors of the Hand and Upper Limb, G. Bogumill, Ed., pp. 224–243, Churchill Livingstone, Edinburgh, UK, 1993.
- J. M. Geoghegan, J. Forbes, D. I. Clark, C. Smith, and R. Hubbard, “Dupuytren's disease risk factors,” Journal of Hand Surgery, vol. 29, no. 5, pp. 423–426, 2004.
- J. J. Rodrigo, J. J. Niebauer, R. L. Brown, and J. R. Doyle, “Treatment of Dupuytren's contracture. Long term results after fasciotomy and fascial excision,” Journal of Bone and Joint Surgery. American, vol. 58, no. 3, pp. 380–387, 1976.
- R. A. Allen, L. B. Woolner, and R. K. Ghormley, “Soft-tissue tumors of the sole; with special reference to plantar fibromatosis,” Journal of Bone and Joint Surgery. American, vol. 37, no. 1, pp. 14–26, 1955.
- S. A. Sintzoff Jr., I. Gillard, D. Gansbeke, P. A. Gevenois, I. Salmon, and J. Struyven, “Ultrasound evaluation of soft tissue tumors,” Journal Belge de Radiologie, vol. 75, no. 4, pp. 276–280, 1992.
- H. Pham, D. P. Fessell, J. E. Femino, S. Sharp, J. A. Jacobson, and C. W. Hayes, “Pictorial essay. Sonography and MR imaging of selected benign masses in the ankle and foot,” American Journal of Roentgenology, vol. 180, no. 1, pp. 99–107, 2003.
- M. J. Kransdorf and M. D. Murphey, “MR imaging of musculoskeletal tumors of the hand and wrist.,” Magnetic resonance imaging clinics of North America, vol. 3, no. 2, pp. 327–344, 1995.
- M. E. Yacoe, A. G. Bergman, A. L. Ladd, and B. H. Hellman, “Dupuytren's contracture: MR imaging findings and correlation between MR signal intensity and cellularity of lesions,” American Journal of Roentgenology, vol. 160, no. 4, pp. 813–817, 1993.
- E. A. Walker, M. E. Fenton, J. S. Salesky, and M. D. Murphey, “Magnetic resonance imaging of benign soft tissue neoplasms in adults,” Radiologic Clinics of North America, vol. 49, no. 6, pp. 1197–1217, 2011.
- P. A. Dinauer, C. J. Brixey, J. T. Moncur, J. C. Fanburg-Smith, and M. D. Murphey, “Pathologic and MR imaging features of benign fibrous soft-tissue tumors in adults,” Radiographics, vol. 27, no. 1, pp. 173–187, 2007.
- T. H. Lee, K. L. Wapner, and P. J. Hecht, “Plantar fibromatosis,” Journal of Bone and Joint Surgery. American, vol. 75, no. 7, pp. 1080–1084, 1993.
- J. F. Fetsch, W. B. Laskin, and M. Miettinen, “Palmar-plantar fibromatosis in children and preadolescents: a clinicopathologic study of 56 cases with newly recognized demographics and extended follow-up information,” The American Journal of Surgical Pathology, vol. 29, no. 8, pp. 1095–1105, 2005.
- E. Aviles, M. Arlen, and T. Miller, “Plantar fibromatosis,” Surgery, vol. 69, no. 1, pp. 117–120, 1971.
- W. B. Morrison, M. E. Schweitzer, K. L. Wapner, and R. D. Lackman, “Plantar fibromatosis: a benign aggressive neoplasm with a characteristic appearance on MR images,” Radiology, vol. 193, no. 3, pp. 841–845, 1994.
- M. R. Robbin, M. D. Murphey, H. T. Temple, M. J. Kransdorf, and J. J. Choi, “Imaging of musculoskeletal fibromatosis,” Radiographics, vol. 21, no. 3, pp. 585–600, 2001.
- F. V. Aluisio, S. D. Mair, and R. L. Hall, “Plantar fibromatosis: treatment of primary and recurrent lesions and factors associated with recurrence,” Foot and Ankle International, vol. 17, no. 11, pp. 672–678, 1996.
- J. F. Griffith, T. Y. Y. Wong, S. M. Wong, M. W. N. Wong, and C. Metreweli, “Sonography of plantar fibromatosis,” American Journal of Roentgenology, vol. 179, no. 5, pp. 1167–1172, 2002.
- D. W. Haun, J. C. Cho, and N. W. Kettner, “Symptomatic plantar fibroma with a unique sonographic appearance,” Journal of Clinical Ultrasound, vol. 40, no. 2, pp. 112–114, 2012.
- M. Sundaram, H. Duffrin, M. H. McGuire, and W. Vas, “Synchronous multicentric desmoid tumors (aggressive fibromatosis) of the extremities,” Skeletal Radiology, vol. 17, no. 1, pp. 16–19, 1988.
- J. J. Reitamo, P. Hayry, E. Nykyri, and E. Saxen, “The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population,” American Journal of Clinical Pathology, vol. 77, no. 6, pp. 665–673, 1982.
- I. Dahn, N. Jonsson, and G. Lundh, “Desmoid tumours: a series of 33 cases,” Acta Chirurgica Scandinavica, vol. 126, pp. 305–314, 1963.
- A. W. Sauter, J. T. Hartmann, and M. S. Horger, “Monitoring response to imatinib using MRI signals in aggressive fibromatosis,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 2, pp. 406–407, 2011.
- G. Pignatti, G. Barbanti-Bròdano, D. Ferrari et al., “Extraabdominal desmoid tumor: a study of 83 cases,” Clinical Orthopaedics and Related Research, no. 375, pp. 207–213, 2000.
- D. J. Pritchard, A. G. Nascimento, and I. A. Petersen, “Local control of extra-abdominal desmoid tumors,” Journal of Bone and Joint Surgery. American, vol. 78, no. 6, pp. 848–854, 1996.
- D. G. Disler, A. A. Alexander, H. J. Mankin, J. X. O'Connell, A. E. Rosenberg, and D. I. Rosenthal, “Multicentric fibromatosis with metaphyseal dysplasia,” Radiology, vol. 187, no. 2, pp. 489–492, 1993.
- M. G. Rock, D. J. Pritchard, and H. M. Reiman, “Extra-abdominal desmoid tumors,” Journal of Bone and Joint Surgery. American, vol. 66, no. 9, pp. 1369–1374, 1984.
- H. S. Hosalkar, J. T. Torbert, E. J. Fox, T. F. Delaney, A. J. Aboulafia, and R. D. Lackman, “Musculoskeletal desmoid tumors,” Journal of the American Academy of Orthopaedic Surgeons, vol. 16, no. 4, pp. 188–198, 2008.
- R. N. Berri, D. P. Baumann, J. E. Madewell, A. Lazar, and R. E. Pollock, “Desmoid tumor: current multidisciplinary approaches,” Annals of Plastic Surgery, vol. 67, no. 5, pp. 551–564, 2011.
- H. Ilaslan, J. Schils, M. Joyce, K. Marks, and M. Sundaram, “Radiofrequency ablation: another treatment option for local control of desmoid tumors,” Skeletal Radiology, vol. 39, no. 2, pp. 169–173, 2010.
- C. L. Lim, M. J. Walker, R. R. Mehta, and T. K. Das Gupta, “Estrogen and antiestrogen binding sites in desmoid tumors,” European Journal of Cancer and Clinical Oncology, vol. 22, no. 5, pp. 583–587, 1986.
- N. Wilcken and M. H. N. Tattersall, “Endocrine therapy for desmoid tumors,” Cancer, vol. 68, no. 6, pp. 1384–1388, 1991.
- W. R. Waddell and W. M. Kirsch, “Testolactone, sulindac, warfarin, and vitamin K1 for unresectable desmoid tumors,” The American Journal of Surgery, vol. 161, no. 4, pp. 416–421, 1991.
- H. J. Griffiths, K. Robinson, and T. A. Bonfiglio, “Aggressive fibromatosis,” Skeletal Radiology, vol. 9, no. 3, pp. 179–184, 1982.
- S. Terui, T. Terauchi, H. Abe et al., “Role of technetium-99m pertechnetate scintigraphy in the management of extra-abdominal fibromatosis,” Skeletal Radiology, vol. 24, no. 5, pp. 331–336, 1995.
- J. Y. Lee, S. M. Kim, D. P. Fessell, and J. A. Jacobson, “Sonography of benign palpable masses of the elbow,” Journal of Ultrasound in Medicine, vol. 30, no. 8, pp. 1113–1119, 2011.
- E. Y. Kim, B. K. Han, H. S. Jung et al., “Sonography of axillary masses: what should be considered other than the lymph nodes?” Journal of Ultrasound in Medicine, vol. 28, no. 7, pp. 923–939, 2009.
- H. K. Jung, E. K. Kim, K. H. Ko, and H. Y. Kang, “Breast fibromatosis showing unusual sonographic features,” Journal of Ultrasound in Medicine, vol. 29, no. 11, pp. 1671–1674, 2010.
- W. A. Rubenstein, G. Gray, and Y. H. Auh, “CT of fibrous tissues and tumours with sonographic correlation,” American Journal of Roentgenology, vol. 147, no. 5, pp. 1067–1074, 1986.
- C. A. Kingston, C. M. Owens, A. Jeanes, and M. Malone, “Imaging of desmoid fibromatosis in pediatric patients,” American Journal of Roentgenology, vol. 178, no. 1, pp. 191–199, 2002.
- Y. Wang, J. Tang, and Y. Luo, “Sonographic diagnosis of fibromatosis,” Journal of Clinical Ultrasound, vol. 36, no. 6, pp. 330–334, 2008.
- J. Casillas, G. J. Sais, J. L. Greve, M. C. Iparraguirre, and G. Morillo, “Imaging of intra- and extraabdominal desmoid tumors.,” Radiographics, vol. 11, no. 6, pp. 959–968, 1991.
- C. C. Huang, S. F. Ko, M. C. Yeh et al., “Aggressive fibromatosis of the chest wall: sonographic appearance of the fascial tail and staghorn patterns,” Journal of Ultrasound in Medicine, vol. 28, no. 3, pp. 393–396, 2009.
- M. Michel, J. Ninane, D. Claus, S. Gosseye, F. X. Wese, and D. Moulin, “Major malformations in a case of infantile myofibromatosis,” European Journal of Pediatrics, vol. 149, no. 4, pp. 251–252, 1990.
- I. R. Francis, K. Dorovini-Zis, and G. M. Glazer, “The fibromatoses: CT-pathologic correlation,” American Journal of Roentgenology, vol. 147, no. 5, pp. 1063–1066, 1986.
- T. M. Hudson, R. A. Vandergriend, and D. S. Springfield, “Aggressive fibromatosis: evaluation by computed tomography and angiography,” Radiology, vol. 150, no. 2, pp. 495–501, 1984.
- M. Sundaram, M. H. McGuire, and F. Schajowicz, “Soft-tissue masses: histologic basis for decreased signal (short T2) on T2-weighted MR images,” American Journal of Roentgenology, vol. 148, no. 6, pp. 1247–1250, 1987.
- H. E. L. Teo, W. C. G. Peh, and T. W. H. Shek, “Case 84: desmoid tumor of the abdominal wall,” Radiology, vol. 236, no. 1, pp. 81–84, 2005.
- J. E. Vandevenne, A. M. de Schepper, L. de Beuckeleer et al., “New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions,” European Radiology, vol. 7, no. 7, pp. 1013–1019, 1997.
- J. C. Lee, J. M. Thomas, S. Phillips, C. Fisher, and E. Moskovic, “Aggressive fibromatosis: MRI features with pathologic correlation,” American Journal of Roentgenology, vol. 186, no. 1, pp. 247–254, 2006.
- J. A. Romero, E. E. Kim, C. G. Kim, W. K. Chung, and I. Isiklar, “Different biologic features of desmoid tumors in adult and juvenile patients: MR demonstration,” Journal of Computer Assisted Tomography, vol. 19, no. 5, pp. 782–787, 1995.
- M. J. Kransdorf, J. S. Jelinek, R. P. Moser et al., “Magnetic resonance appearance of fibromatosis: a report of 14 cases and review of the literature,” Skeletal Radiology, vol. 19, no. 7, pp. 495–499, 1990.
- S. F. Quinn, S. J. Erickson, P. M. Dee et al., “MR imaging in fibromatosis: results in 26 patients with pathologic correlation,” American Journal of Roentgenology, vol. 156, no. 3, pp. 539–542, 1991.
- K. Oka, T. Yakushiji, H. Sato et al., “Usefulness of diffusion-weighted imaging for differentiating between desmoid tumors and malignant soft tissue tumors,” Journal of Magnetic Resonance Imaging, vol. 33, no. 1, pp. 189–193, 2011.
- S. Basu, N. Nair, and S. Banavali, “Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management,” British Journal of Radiology, vol. 80, no. 957, pp. 750–756, 2007.
- B. Kasper, A. Dimitrakopoulou-Strauss, L. G. Strauss, and P. Hohenberger, “Positron emission tomography in patients with aggressive fibromatosis/desmoid tumours undergoing therapy with imatinib.,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 10, pp. 1876–1882, 2010.
- C. Pfeiffer, “Die Desmoide der Bauchdecken und ihre Prognose,” Beitraege Zur Klinische Chirurgie, vol. 44, pp. 334–401, 1904.
- S. G. Krishna, R. Suzuki, and M. S. Bhutani, “A first report of endoscopic ultrasound-guided biopsy in the diagnosis of desmoid-type fibromatosis,” Endoscopy, vol. 43, supplement 2, pp. E417–E418, 2011.
- H. Lipshutz, “Painful knuckle pads,” Plastic and Reconstructive Surgery and the Transplantation Bulletin, vol. 28, pp. 420–421, 1961.
- L. Picariello, F. Tonelli, and M. L. Brandi, “Selective oestrogen receptor modulators in desmoid tumours,” Expert Opinion on Investigational Drugs, vol. 13, no. 11, pp. 1457–1468, 2004.
- E. S. Siegelman, Body MRI, Elsevier Saunders, Philadelphia, Pa, USA, 1st edition, 2005.
- C. B. Chen, Y. Y. Chiou, C. H. Chen, Y. H. Chou, J. H. Chiang, and C. Y. Chang, “Sonographic and computed tomography findings of intra-abdominal desmoid tumor,” Journal of the Chinese Medical Association, vol. 73, no. 7, pp. 393–395, 2010.
- J. W. Mall, A. W. Philipp, M. Zimmerling, and R. Büttemeyer, “Desmoid tumours following long-term Tenckhoff peritoneal dialysis catheters,” Nephrology Dialysis Transplantation, vol. 17, no. 5, pp. 945–946, 2002.
- A. K. Gurbuz, F. M. Giardiello, G. M. Petersen et al., “Desmoid tumours in familial adenomatous polyposis,” Gut, vol. 35, no. 3, pp. 377–381, 1994.
- I. Heiskanen and H. J. Järvinen, “Occurrence of desmoid tumours in familial adenomatous polyposis and results of treatment,” International Journal of Colorectal Disease, vol. 11, no. 4, pp. 157–162, 1996.
- M. A. Rodriguez-Bigas, M. C. Mahoney, C. P. Karakousis, and N. J. Petrelli, “Desmoid tumors in patients with familial adenomatous polyposis,” Cancer, vol. 74, no. 4, pp. 1270–1274, 1994.
- A. Sørensen, J. Keller, O. S. Nielsen, and O. M. Jensen, “Treatment of aggressive fibromatosis: a retrospective study of 72 patients followed for 1–27 years,” Acta Orthopaedica Scandinavica, vol. 73, no. 2, pp. 213–219, 2002.
- M. Bernathova, M. Felfernig, F. Rachbauer et al., “Sonographic imaging of abdominal and extraabdominal desmoids,” Ultraschall in der Medizin, vol. 29, no. 5, pp. 515–519, 2008.
- E. Montgomery, M. S. Torbenson, M. Kaushal, C. Fisher, and S. C. Abraham, “β-Catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis,” The American Journal of Surgical Pathology, vol. 26, no. 10, pp. 1296–1301, 2002.
- A. D. Levy, J. Rimola, A. K. Mehrotra, and L. H. Sobin, “From the archives of the AFIP: benign fibrous tumors and tumorlike lesions of the mesentery: radiologic-pathologic correlation,” Radiographics, vol. 26, no. 1, pp. 245–264, 2006.
- A. P. Burke, L. H. Sobin, and K. M. Shekitka, “Mesenteric fibromatosis: a follow-up study,” Archives of Pathology and Laboratory Medicine, vol. 114, no. 8, pp. 832–835, 1990.
- A. P. Burke, L. H. Sobin, K. M. Shekitka, B. H. Federspiel, and E. B. Helwig, “Intra-abdominal fibromatosis: a pathologic analysis of 130 tumors with comparison of clinical subgroups,” The American Journal of Surgical Pathology, vol. 14, no. 4, pp. 335–341, 1990.
- R. L. Baron and J. K. T. Lee, “Mesenteric desmoid tumors. Sonographic and computed-tomographic appearance,” Radiology, vol. 140, no. 3, pp. 777–779, 1981.
- E. A. Walker, A. J. Song, and M. D. Murphey, “Magnetic resonance imaging of soft-tissue masses,” Seminars in Roentgenology, vol. 45, no. 4, pp. 277–297, 2010.
- G. M. Rayan, “Dupuytren disease: anatomy, pathology, presentation, and treatment,” Journal of Bone and Joint Surgery. American, vol. 89, no. 1, pp. 190–198, 2007.
- L. Azizi, M. Balu, A. Belkacem, M. Lewin, J. M. Tubiana, and L. Arrivé, “MRI features of mesenteric desmoid tumors in familial adenomatous polyposis,” American Journal of Roentgenology, vol. 184, no. 4, pp. 1128–1135, 2005.
- D. M. Einstein, J. R. Tagliabue, and R. K. Desai, “Abdominal desmoids: CT findings in 25 patients,” American Journal of Roentgenology, vol. 157, no. 2, pp. 275–279, 1991.
- S. Sheth, K. M. Horton, M. R. Garland, and E. K. Fishman, “Mesenteric Neoplasms: CT appearances of primary and secondary tumors and differential diagnosis,” Radiographics, vol. 23, no. 2, pp. 457–473, 2003, quiz 535–536.
- A. Sinha, A. Hansmann, S. Bhandari, et al., “Imaging assessment of desmoid tumours in familial adenomatous polyposis: is state-of-the-art 1.5 T MRI better than 64-MDCT?” The British Journal of Radiology. In press.
- J. C. Healy, R. H. Reznek, S. K. Clark, R. K. S. Phillips, and P. Armstrong, “MR appearances of desmoid tumors in familiar adenomatous polyposis,” American Journal of Roentgenology, vol. 169, no. 2, pp. 465–472, 1997.
- Z. Zhu, F. Li, H. Zhuang, J. Yan, C. Wu, and W. Cheng, “FDG PET/CT detection of intussusception caused by aggressive fibromatosis,” Clinical Nuclear Medicine, vol. 35, no. 5, pp. 370–373, 2010.
- K. W. K. Lo, “Mesenteric fibromatosis as a potential source of false-positive interpretation of FDG-PET: report of a case,” Diseases of the Colon and Rectum, vol. 50, no. 6, pp. 924–926, 2007.
- D. Kotiligam, A. J. F. Lazar, R. E. Pollock, and D. Lev, “Desmoid tumor: a disease opportune for molecular insights,” Histology and Histopathology, vol. 23, no. 1–3, pp. 117–126, 2008.
- W. Bessler, B. Egloff, and H. Sulser, “Case report 253,” Skeletal Radiology, vol. 11, no. 1, pp. 56–59, 1984.
- A. Kawashima, S. M. Goldman, E. K. Fishman et al., “CT of intraabdominal desmoid tumors: is the tumor different in patients with Gardner's disease?” American Journal of Roentgenology, vol. 162, no. 2, pp. 339–342, 1994.
- S. Sevak, A. L. Blount, S. Cottingham et al., “Fibromatosis of the cervical region following laminectomy: a case report and literature review,” Spine, vol. 37, no. 7, pp. E456–E459, 2012.
- G. Tonini, F. Kalantary, A. Teppa, et al., “Sporadic case of desmoid tumor in outcomes of lombotomic nephrectomy,” Urologia, vol. 78, no. 3, pp. 206–209, 2011.
- E. Sonmez, N. Altinors, S. Gulsen, and O. Ozen, “Extraabdominal desmoid tumor appearing following resection of toracolumbar schwannoma,” Turkish Neurosurgery, vol. 21, no. 2, pp. 246–248, 2011.
- M. L. Arvanitis, D. G. Jagelman, V. W. Fazio, I. C. Lavery, and E. McGannon, “Mortality in patients with familial adenomatous polyposis,” Diseases of the Colon and Rectum, vol. 33, no. 8, pp. 639–642, 1990.